Neopathology
1 known investors
Neopathology develops tissue diagnostic assays and a proprietary platform called ONEPATHOLOGY that delivers rapid, accurate disease diagnosis and patient stratification for precision medicine treatments. The company combines spatial biology and deep-tissue profiling technologies to standardize tissue diagnostics.
BiotechHealthtechMedical Devices